Torrent Pharma acquires US-based drug firm for $120M

Torrent Pharma acquires US-based drug firm for $120M.

The company has acquired a US-based pharmaceutical business for $120 million, expanding its footprint in the highly regulated US generics market. This strategic move is expected to enhance its product portfolio and revenue stream. The acquisition is funded through internal accruals and debt.

📊 STOCKS: $TORNTPHARM | 🏢 SECTOR: Pharma | #HIGHIMPACT #Acquisition